Mirum Pharmaceuticals, Inc. (MIRM)

Mirum Pharmaceuticals Revenue

Mirum Pharmaceuticals had revenue of $185.72M in the quarter ending September 30, 2026, with 39.63% growth. This brings the company's total for the last twelve months to $670.78M, up 42.18% year-over-year. In the year 2025, Mirum Pharmaceuticals had annual revenue of $521.31M with 54.74% growth. That makes Mirum Pharmaceuticals the 9,637th largest company in the world by revenue and 2,099th in the United States.

• Revenue (ttm): $670.78M
• Revenue Growth: +42.18%
• P/S Ratio: 9.12
• Revenue / Employee: $1,427,187
• Employees: 470
• Market Cap: 6.12B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Livmarli 360.01M 69.1%
• Bile Acid Medicines 161.31M 30.9%

By Geography

Chart

• United States - Product 401.55M 77.0%
• Rest of the World - Product 119.77M 23.0%

Fiscal year ended Dec 31, 2025 See the full Mirum Pharmaceuticals breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	521.31M	184.42M	54.74%
Dec 31, 2024	336.89M	150.51M	80.76%
Dec 31, 2023	186.37M	109.31M	141.85%
Dec 31, 2022	77.06M	57.92M	302.66%
Dec 31, 2021	19.14M	-	-

Data Sources: S&P Global Market Intelligence and Fiscal.ai Last updated: Nov 3, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company. Revenue segment and geography data is provided by Fiscal.ai.

Update frequency:

Quarterly

Last checked:

Nov 8, 2026

Data Sources Report a data error